✦ LIBER ✦

Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan

✍ Scribed by Hattori, Motoshi; Uemura, Osamu; Hataya, Hiroshi; Ito, Shuichi; Hisano, Masataka; Ohta, Toshiyuki; Fujinaga, Shuichiro; Kise, Tomoo; Gotoh, Yoshimitsu; Matsunaga, Akira; Ito, Naoko; Akizawa, Tadao

Book ID: 125352937
Publisher: Springer
Year: 2013
Tongue: English
Weight: 497 KB
Volume: 18
Category: Article
ISSN: 1342-1751
DOI: 10.1007/s10157-013-0859-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Darbepoetin alfa for the treatment of an

Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan

✍ Hattori, Motoshi; Matsunaga, Akira; Akioka, Yuko; Fujinaga, Shuichiro; Nagai, Ta 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 963 KB

Darbepoetin alfa for the treatment of an

Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease

✍ Bradley A. Warady; Mazen Y. Arar; Gary Lerner; Arline M. Nakanishi; Catherine St 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 179 KB

Efficacy and safety of alendronate for t

Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: A prospective multicenter study

✍ Maria Luisa Bianchi; Rolando Cimaz; Maria Bardare; Francesco Zulian; Loredana Le 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Values are the number of patients or the mean Ϯ SD. † Behçet's syndrome (2 patients), Wegener's granulomatosis (1 patient), and undefined connective tissue disease (2 patients). ‡ Prednisone equivalents.

Omeprazole for treatment of chronic eros

Omeprazole for treatment of chronic erosive esophagitis in children: A multicenter study of efficacy, safety, tolerability and dose requirements

✍ Eric Hassall; David Israel; Ross Shepherd; Michael Radke; Agneta Dalväg; Birgitt 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 107 KB

A multicenter, double-blind, randomized

A multicenter, double-blind, randomized safety and efficacy study of two dose levels of taliglucerase alfa in pediatric patients with Gaucher disease

✍ Zimran, Ari; Gonzalez-Rodriguez, Derlis Emilio; Abrahamov, Aya; Elstein, Deborah 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

An open-label study of darbepoetin alfa

An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis

✍ A. K. AGARWAL; M. R. SILVER; J. E. REED; R. K. DHINGRA; W. LIU; N. VARMA; C. STE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB